Coverage of our peer-reviewed research in the healthcare and mainstream press.
A study from the May 2017 issue of The American Journal of Managed Care® (AJMC®) was discussed in a press release from Pennsylvania State University. In “State Prescription Drug Monitoring Programs and Fatal Drug Overdoses,” Penn State researchers found that prescription drug monitoring programs (PDMPs) were not associated with reduced mortality rates from prescription opioid overdoses. However, study co-author Yungfeng Shi, PhD, noted in the statement that the “results point to a potential unintended consequence of PDMPs, whereby reduced access to prescription drugs may have led some individuals with addictive disorders to look for alternatives.”
An article published by Huffington Post warned readers of “The Over-the-Counter Drug Reactions You Should Watch Out For,” including adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs). It cited a 2013 study published in an AJMC® supplement that showed that NSAID-related complications can be serious and costly. The report, “Quantifying the Impact of NSAID-Associated Adverse Events,” found that gastrointestinal complications from the painkillers are responsible for more than $4 billion in medical costs annually.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More